Xenon Pharmaceuticals Inc Q3 2024 Earnings Call Highlights Strategic Advancements and ...

XENE Stock  USD 40.51  0.34  0.85%   
About 60% of all Xenon Pharmaceuticals' shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Cash and Cash Equivalents 803.3 million as of September 30, 2024.Cash and Cash Equivalents 930.9 million as of December 31, 2023.Cash Runwa

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Xenon Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Xenon Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Xenon Pharmaceuticals Maximum Pain Price Across January 17th 2025 Option Contracts

Xenon Pharmaceuticals' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Xenon Pharmaceuticals close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Xenon Pharmaceuticals' options.

Xenon Pharmaceuticals Fundamental Analysis

We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Xenon Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Xenon Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Xenon Pharmaceuticals Related Equities

VTYXVentyx Biosciences   16.36   
0%
100.0%
ANABAnaptysBio   9.28   
0%
56.0%
LYELLyell Immunopharma   7.69   
0%
47.0%
INBXInhibrx   5.90   
0%
36.0%
IDYAIdeaya Biosciences   3.34   
0%
20.0%
CRNXCrinetics Pharmaceuticals   3.10   
0%
18.0%
KRONKronos Bio   3.09   
0%
18.0%
EWTXEdgewise Therapeutics   2.55   
0%
15.0%
MGTXMeiraGTx Holdings   2.39   
0%
14.0%
VRDNViridian Therapeutics   2.18   
0%
13.0%
MRUSMerus BV   2.03   
0%
12.0%
PCVXVaxcyte   1.87   
0%
11.0%
ASNDAscendis Pharma   1.74   
0%
10.0%
KROSKeros Therapeutics   1.13   
0%
6.0%
NUVLNuvalent   0.99   
0%
6.0%
CYTKCytokinetics   0.88   
0%
5.0%
ACLXArcellx   0.48   
0%
2.0%
REPLReplimune   0.48   
0%
2.0%
UTHRUnited Therapeutics   1.08   
6.0%
0%
DYNDyne Therapeutics   2.75   
16.0%
0%

Complementary Tools for Xenon Stock analysis

When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities